These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25944168)

  • 1. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S; Akhtar J; Wang Z
    Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
    Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal expression of the mitotic checkpoint protein BubR1 contributes to the anti-microtubule drug resistance of esophageal squamous cell carcinoma cells.
    Hu M; Liu Q; Song P; Zhan X; Luo M; Liu C; Yang D; Cai Y; Zhang F; Jiang F; Zhang Y; Tang M; Zuo G; Zhou L; Luo J; Shi Q; Weng Y
    Oncol Rep; 2013 Jan; 29(1):185-92. PubMed ID: 23128493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stathmin 1 silencing by siRNA on sensitivity of esophageal cancer cells Eca-109 to paclitaxel.
    Zhu HW; Jiang D; Xie ZY; Zhou MH; Sun DY; Zhao YG
    Genet Mol Res; 2015 Dec; 14(4):18695-702. PubMed ID: 26782519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming paclitaxel resistance in lung cancer cells via dual inhibition of stathmin and Bcl-2.
    Han ZX; Wang HM; Jiang G; Du XP; Gao XY; Pei DS
    Cancer Biother Radiopharm; 2013 Jun; 28(5):398-405. PubMed ID: 23496232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential sensitivity of paclitaxel-induced apoptosis in human esophageal squamous cell carcinoma cell lines.
    Faried A; Faried LS; Kimura H; Sohda M; Nakajima M; Miyazaki T; Kato H; Kanuma T; Kuwano H
    Cancer Chemother Pharmacol; 2006 Feb; 57(3):301-8. PubMed ID: 16028102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells.
    Wu Y; Tang M; Wu Y; Weng X; Yang L; Xu W; Yi W; Gao J; Bode AM; Dong Z; Cao Y
    Cell Oncol (Dordr); 2014 Feb; 37(1):53-67. PubMed ID: 24306928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P; Yokobori T; Altan B; Iijima M; Azuma Y; Onozato R; Yajima T; Watanabe A; Mogi A; Shimizu K; Nagashima T; Ohtaki Y; Obayashi K; Nakazawa S; Bai T; Kawabata-Iwakawa R; Asao T; Kaira K; Nishiyama M; Kuwano H
    Ann Surg Oncol; 2017 Dec; 24(13):4017-4024. PubMed ID: 28933054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STMN1, a prognostic predictor of esophageal squamous cell carcinoma, is a marker of the activation of the PI3K pathway.
    Jiang W; Huang S; Song L; Wang Z
    Oncol Rep; 2018 Feb; 39(2):834-842. PubMed ID: 29251330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing stathmin-modulating efficiency of chemotherapy for esophageal squamous cell cancer with paclitaxel.
    Feng W; Xiaoyan X; Xuan Y; Xiangke L; Zichang Y; Ran Z; Liuxing W; Qingxia F
    Cancer Gene Ther; 2015 Apr; 22(3):115-21. PubMed ID: 25572118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.
    Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M
    J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.
    Alli E; Yang JM; Ford JM; Hait WN
    Mol Pharmacol; 2007 May; 71(5):1233-40. PubMed ID: 17272681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
    Alli E; Bash-Babula J; Yang JM; Hait WN
    Cancer Res; 2002 Dec; 62(23):6864-9. PubMed ID: 12460900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression.
    Song Y; Mu L; Han X; Li Q; Dong B; Li H; Liu X
    J Neurooncol; 2013 Dec; 115(3):381-90. PubMed ID: 24043603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Kojima H; Okumura T; Yamaguchi T; Miwa T; Shimada Y; Nagata T
    Int J Oncol; 2017 Jul; 51(1):49-62. PubMed ID: 28534989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin induced-growth inhibition and apoptosis of human esophageal squamous carcinoma cell line Eca109 cells in vitro.
    Wang TT; Wang SK; Huang GL; Sun GJ
    Asian Pac J Cancer Prev; 2012; 13(11):5455-61. PubMed ID: 23317200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.